| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.039 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |